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Introduction
Lung cancer is the leading cause of cancer-related death. Besides traditional treatments, new modalities are under investigation; internal radiotherapy, like radio-immunotherapy (RIT), is a promising example. RIT is a biologically targeted radio-pharmaceutical treatment in which a radioactive isotope is chemically bound to a target-specific monoclonal antibody or antibody fragments with a high degree of specificity for one particular tumor associated antigen (Pohlman et al. 2006) . RIT requires dealing with three interdependent factors: the tumor targeted by the treatment, the antibody and the radionuclide. Howell et al. (Howell et al. 1994) and Rao et al. (Rao & Howell 1993 ) have
shown that one of the most promising radioisotope for RIT is 32 P owing to its half life (14.3 days) and the tissue penetration of its beta radiation (8 mm maximum). Initially, this radioisotope was mainly used for the therapy of bone pain and metastases, in ovarian cancer and for myeloproliferative diseases (Pattillo et al. 1995; Berlin 2000; PanditTaskar et al. 2004; Tennvall & Brans 2007) . More recently, studies on the use of 32 P as colloid or microsphere for solid tumors were performed; they showed not only an improvement in the patient's quality of life, but also in their survival (Gao et al. 2008; Wang et al. 2008 ). However, 32 P was not used in RIT due to the difficulty of the radiolabeling. Abraham and colleagues used decapeptides labeled with 32 P for the colorectal cancer therapy (Abraham et al. 2007; Abraham et al. 2008) and showed that these molecules avidly bind to different adenocarcinoma cell lines with a permanent incorporation of radioisotopes into cellular proteins at a rate over 100 times greater than in cell lines derived from a variety of other cancers or from normal organs. The use of such small molecules allows for their elimination in the urine, as their molecular weight is lower than the limit of the filtering kidney. Moreover, they can penetrate deeper into the tumor, which is, in combination with the long penetrating range of the 32 P beta (Bouchat et al. 2007; Nuttens et al. 2008) . Nevertheless, the currently achievable dose-rate in RIT is one or two orders of magnitude lower than the one obtained by external X-ray radiotherapy.
One major question still remains: is it possible to obtain adequate cell sterilization with beta radiation with a dose-rate that is one or two orders of magnitude lower than with traditional X-rays? The aim of this work is to try to answer this question by studying the clonogenic survival of human A549 adenocarcinoma non-small cell lung cells irradiated with beta radiation emitted by 32 P (0.8 Gy/h) and to compare the results with data obtained with X-ray irradiation (0.855 Gy/min). A549 cells were exposed to X-rays (RT250, Philips Medical Systems, Bruxelles, Belgium) at 0.855 Gy/min (51.3 Gy/h) in the same condition as for 32 P.
Materials and Methods
Dosimetry simulation
The deposited dose was calculated by MCNPX (Monte Carlo N-Particle eXtended)
simulations (Pelowitz 2005 ) (code version 2.5.0) according to the calculation method proposed by Schaart et al. (Schaart et al. 2002) to assess the dose deposited by 32 P in a solution of Na 2 H 32 PO 4 on A549 cells. It treats a three dimensional configuration of materials in geometric cells bounded by first-and second-degree surfaces and fourthdegree elliptical tori (Pelowitz 2005) . Working with charged particles as electrons in very small geometric cells leads to some uncertainties that are inherent in the condensed history method. Indeed, Schaart et al. have shown that this leads to significant errors in the absorbed dose (Schaart et al. 2002) . They proposed a new method, used here proper evaluation. The calculations were performed using the track length estimator tally F4, combined with a dose response function. The ITS (Integrated Tiger Series) energy indexing algorithm was used (Debug Information Card: DBCN 17j 1). The photon and electron energy cut-offs were set to 1 keV as particles with less energy can not pass through the culture medium and reach the biological cells to damage them. The geometry of the experiment was a culture well whose bottom was covered by A549 cells (one confluent monolayer). The plastic well was filled with a radioactive 32 P aqueous solution.
The cell chemical composition was taken from the National Institute of Standards and
Technology data base (NIST).
The cell thickness was experimentally measured by confocal microscopy after immunofluorescence staining. An average thickness of 3.2 µm  0.1 µm was obtained over more than 30 measurements.
Knowing the cell thickness, it was possible to evaluate the dose delivered by using the Tally T value. The obtained values were 7.047 10 -2 and 6.200 10 -1 MeV/g/nps for 6-well and 24-well plates, respectively. This corresponds to the mean deposited energy (MeV)
for an incident particle (nps) per mass unit (g). This value can be converted to dose-rate ( D ) in Gy/h using:
where A is the source activity (mCi) that gives the number of emitted beta particles per unit time, and k is the unit conversion constant (equal to 21.34) to obtain the unit of doserate (J/kg/h or Gy/h) from the multiplication of the tally by the activity (MeV/g/s).
The T value is specific to the geometry used in these experiments. As the source activity is 12 mCi/ml, the amount of radioactive solution added to the medium has been adjusted to obtain a dose-rate of 0.8 Gy/h. The exposition time has been adapted to reach the total targeted dose.
The cellular uptake of 32 P into exposed cells after the irradiation was experimentally measured: it was less than 0.05 % for each dose. This result allowed us to neglect the residual activity incorporated into the cells and to consider the total dose equal to the one obtained by the simulations.
Colony-Forming Assay
Two thousand A549 cells were seeded in 6-well plates. Control cells underwent exactly the same manipulations without the addition of the radioisotope for 32 P or without X-ray irradiation. 8 days post-irradiation, the number of visible colonies (containing > 50 cells) was counted after staining cells with crystal violet. The surviving fraction was obtained by calculating the ratio of the colony number for the irradiated cells to the colony number for control cells.
Survival curve analysis
The results obtained from the colony forming assays were analyzed with the LinearQuadratic (LQ) model and the Induced-Repair model (IndRep). The LQ model allows the determination of the two radiosensitivity parameters α and β:
where S is the surviving fraction and D is the deposited dose. The LQ model considers cell killing as the result of single or double hit events into DNA. In different studies, a deviation between experimental data and the LQ model was observed. This deviation is due to hyper-radiosensitivity (HRS) which has been reviewed in (Raaphorst & Boyden 1999; Joiner et al. 2001; Leskov et al. 2003; Marples et al. 2004) . To obtain a better approximation of the data at low doses, the Induced-Repair model has been suggested to match this HRS as well as the induced radioresistance observed by increasing doses until 1 Gy. The surviving fractions were fitted using Origin 7.5 (OriginLab) using a chi-square minimization method.
Results
Survival curves for 32 P irradiation
The irradiations were performed at 0.8 Gy/h for doses ranging from 0.125 to 10 Gy. This dose-rate is within the usual range used in RIT and can be considered as a low-dose-rate.
Four independent irradiation experiments with at least 4 replicates each were performed ( Figure 1A ). The experimental data were fitted with both LQ and IndRep models. The LQ model gave parameters equal to 0.21 ± 0.02 Gy -1 and 0.019 ± 0.002 Gy -2 for α and β respectively. The ratio α/β is 11.0 ± 2.1 Gy. At low doses from 0.125 to 0.5 Gy, a deviation between experimental data and the LQ model was observed (inset of Figure   1A ). This deviation is due to HRS and is highlighted by linearization of the surviving fraction ( Figure 1B) . A better approximation of the data at low doses was obtained with the IndRep model (see fit in Figures 1A and 1B) . The values obtained for α s and D c are, respectively, 2.1 ± 1.2 Gy -1 and 0.27 ± 0.10 Gy. The ratio α s /α r is equal to 10.4 ± 6.9, indicating that cells are about ten times more sensitive at very low doses than at higher doses.
Survival curves for X-ray irradiation
The surviving fraction of A549 cells after X-ray irradiation (0.855 Gy/min) is shown in Figure 2A . The experimental data were fitted with both LQ and IndRep models. The parameters obtained with LQ model are 0.14 ± 0.02 Gy -1 and 0.038 ± 0.003 Gy -2 for α and β respectively. At low doses from 0.125 to 0.5 Gy, a deviation between experimental data and the LQ model was observed (inset of Figure 2A ). This deviation, highlighted by linearization ( Figure 2B ), is due to HRS and is comparable to the deviation observed for 10 beta particles. The data were fitted with the IndRep model giving a α s value of 1.8 ± 1.2
Gy -1 and a D c value equal to 0.22 ± 0.11 Gy. A comparison was made between the surviving fraction obtained with 32 P and X-ray irradiations (Figure 3 ). We observed a nearly complete overlay between both curves, with the curve for X-ray irradiation being just slightly more shouldered. Although irradiations were performed with serum-free medium to avoid progression in the cell cycle, effects of irradiation time may occur, and if so, influence the surviving fraction. Table I 
Discussion
This work compares the clonogenic survival of A549 cells after low-dose-rate beta irradiations to high-dose-rate X-rays irradiations. For the 32 P exposures, a low-dose-rate of 0.8 Gy/h was chosen. This dose-rate is in the range of those actually used in radionuclide therapy in which beta particles are involved.
The surviving fraction curve showed that 60% of the cells were still able to grow colonies at 2 Gy, this fraction decreased to less than 3 % at 10 Gy. For X-rays, 65% and less than 1% of survival was observed for 2 Gy and 10 Gy respectively.
For the two types of radiations, a deviation from the LQ model was observed at low doses. This low dose hypersensitivity was highlighted in many tumor cell lines and was called hyper-radiosensitivity (HRS) (Joiner et al. 2001) . HRS is usually displayed for doses below 0.5 Gy. Several explanations have been proposed by Joiner et al. (Joiner et al. 2001 ). This phenomenon seems to precede the occurrence of a relative resistance to cell killing by radiation over the dose range of 0.5-1 Gy. Enns et al. (Enns et al. 2004) have also evidenced a HRS for A549 cells but with gamma irradiation. They have shown that HRS is due to apoptotic death and happens during the first cell cycle post-irradiation. for  and  respectively for A549 cells irradiated using 6 MV X-rays produced by a linear accelerator (Bromley et al. 2009) . These values are close to the ones obtained in this work (0.21 Gy -1 and 0.019 Gy -2 ).
The little difference between the results obtained with beta radiation at low dose-rate and high dose-rate X-rays may be surprising, as it is generally thought that the radiation effects increase with the dose-rate. However, many studies have shown what was termed an inverse dose-rate effect (Gridley DS 2005; Sgouros et al. 2007) i.e. the observation that low-dose-rate (LDR) leads to reduced survival compared to high-dose-rate (HDR).
Among the different possible explanations for this observation, a lower activation of the DNA damage sensor ataxia-telangiectasia mutated (ATM) for cells irradiated at LDR compared to HDR was evidenced ). These results suggest that the low ATM activation and the resulting lower rate of phosphorilated histone H2AX (γ-H 2 AX)
led to a lower cell survival, possibly due to an ineffective activation of cell cycle checkpoint and repair mechanisms.
The results obtained in this work are of potential interest when the response of normal tissues is considered: the range of beta particles of 1.75 MeV in lung tissues is about 8 mm. For 250 keV X-rays, only 11% are absorbed within this distance. X-rays will thus depose most of their energy in the surrounding tissues up to 17 cm from the tumor. The 13 use of a beta emitter for lung tumor treatment should allow normal tissues to be spared, as non-targeted irradiation can be avoided due to the radiation range.
Further studies are warranted to confirm the potential of using LDR beta particles for tumor sterilization while sparing normal tissues. 
